questionsmedicales.fr
Actions chimiques et utilisations
Utilisations spécialisées de produits chimiques
Agents séquestrants
Agents séquestrants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication aux métaux
Tests de laboratoire
Évaluation de traitement
Biochimie clinique
Symptômes digestifs
Troubles gastro-intestinaux
Carence nutritionnelle
Tests sanguins
Overdose
Effets indésirables
Symptômes
5
Toxicité au plomb
Symptômes neurologiques
Carence en calcium
Symptômes musculaires
Intoxication au mercure
Symptômes neurologiques
Carence en potassium
Symptômes cardiaques
Prévention
5
Prévention des carences
Nutrition
Exposition aux métaux
Prévention
Cholestérol
Régime alimentaire
Effets indésirables
Conseils médicaux
Traitements
5
Mécanisme d'action
Absorption intestinale
Effets indésirables
Troubles gastro-intestinaux
Administration orale
Formes pharmaceutiques
Intoxication aux métaux
EDTA
Complications
5
Surconsommation
Complications
Utilisation prolongée
Déséquilibres électrolytiques
Interactions médicamenteuses
Absorption
Intoxication au plomb
Complications
Effets à long terme
Troubles métaboliques
Facteurs de risque
5
Facteurs de risque
Carences nutritionnelles
Intoxication au mercure
Risque alimentaire
Carence en calcium
Groupes vulnérables
Intoxication aux métaux
Comportements à risque
Absorption des nutriments
Facteurs influents
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agents séquestrants : Questions médicales les plus fréquentes",
"headline": "Agents séquestrants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agents séquestrants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agents séquestrants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Utilisations spécialisées de produits chimiques",
"url": "https://questionsmedicales.fr/mesh/D020313",
"about": {
"@type": "MedicalCondition",
"name": "Utilisations spécialisées de produits chimiques",
"code": {
"@type": "MedicalCode",
"code": "D020313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chélateurs",
"alternateName": "Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D002614",
"about": {
"@type": "MedicalCondition",
"name": "Chélateurs",
"code": {
"@type": "MedicalCode",
"code": "D002614",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du calcium",
"alternateName": "Calcium Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D065096",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du calcium",
"code": {
"@type": "MedicalCode",
"code": "D065096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.204"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du fer",
"alternateName": "Iron Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D007502",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du fer",
"code": {
"@type": "MedicalCode",
"code": "D007502",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Agents séquestrants",
"alternateName": "Sequestering Agents",
"code": {
"@type": "MedicalCode",
"code": "D064449",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xueli Cao",
"url": "https://questionsmedicales.fr/author/Xueli%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Yu Xiao",
"url": "https://questionsmedicales.fr/author/Yu%20Xiao",
"affiliation": {
"@type": "Organization",
"name": "Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China."
}
},
{
"@type": "Person",
"name": "Erin Huiting",
"url": "https://questionsmedicales.fr/author/Erin%20Huiting",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA."
}
},
{
"@type": "Person",
"name": "Dong Li",
"url": "https://questionsmedicales.fr/author/Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Jie Ren",
"url": "https://questionsmedicales.fr/author/Jie%20Ren",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Production Review of Accelerator-Based Medical Isotopes.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36014532",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27165294"
}
},
{
"@type": "ScholarlyArticle",
"name": "Joint radial trajectory correction for accelerated T",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37245075",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.16479"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study protocol: Optimising patient positioning for the planning of accelerated partial breast radiotherapy for the integrated magnetic resonance linear accelerator: OPRAH MRL.",
"datePublished": "2024-09-17",
"url": "https://questionsmedicales.fr/article/39289753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13014-024-02517-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Stereotactic radiotherapy with CyberKnife and linear accelerator in the management of malignant melanoma].",
"datePublished": "2022-05-28",
"url": "https://questionsmedicales.fr/article/35724389",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of linear accelerator carbon fiber couch on radiotherapy dose.",
"datePublished": "2022-11-08",
"url": "https://questionsmedicales.fr/article/36346802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0277332"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Utilisations spécialisées de produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D020313"
},
{
"@type": "ListItem",
"position": 4,
"name": "Agents séquestrants",
"item": "https://questionsmedicales.fr/mesh/D064449"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agents séquestrants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agents séquestrants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agents séquestrants",
"description": "Comment diagnostiquer une intoxication aux métaux lourds ?\nQuels examens pour évaluer l'efficacité d'un agent séquestrant ?\nQuels symptômes indiquent un besoin d'agents séquestrants ?\nComment identifier une carence nutritionnelle ?\nQuels signes d'overdose d'agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agents séquestrants",
"description": "Quels symptômes d'une carence en fer ?\nComment reconnaître une toxicité au plomb ?\nQuels signes d'une carence en calcium ?\nQuels symptômes d'une intoxication au mercure ?\nComment se manifeste une carence en potassium ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agents séquestrants",
"description": "Comment prévenir les carences nutritionnelles ?\nQuelles mesures pour éviter l'exposition aux métaux lourds ?\nComment réduire le cholestérol par l'alimentation ?\nQuels aliments riches en calcium pour la prévention ?\nComment éviter les effets secondaires des séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agents séquestrants",
"description": "Quels agents séquestrants pour le cholestérol ?\nComment fonctionnent les agents séquestrants ?\nQuels sont les effets secondaires des agents séquestrants ?\nComment administrer un agent séquestrant ?\nQuels agents séquestrants pour les métaux lourds ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agents séquestrants",
"description": "Quelles complications d'une surconsommation d'agents séquestrants ?\nQuels risques d'une utilisation prolongée ?\nComment les agents séquestrants affectent-ils l'absorption des médicaments ?\nQuelles complications liées à l'intoxication au plomb ?\nQuels effets à long terme des agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agents séquestrants",
"description": "Quels facteurs augmentent le risque de carences ?\nQui est à risque d'intoxication au mercure ?\nQuels groupes sont vulnérables aux carences en calcium ?\nQuels comportements augmentent le risque d'intoxication aux métaux ?\nQuels facteurs influencent l'absorption des nutriments ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Particle+Accelerators#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux métaux lourds ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer l'efficacité d'un agent séquestrant ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'agents séquestrants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment identifier une carence nutritionnelle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent révéler des carences en vitamines ou minéraux."
}
},
{
"@type": "Question",
"name": "Quels signes d'overdose d'agents séquestrants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, vomissements ou diarrhées peuvent signaler une overdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une carence en fer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une toxicité au plomb ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes d'une carence en calcium ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication au mercure ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une carence en potassium ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences nutritionnelles ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et variée est essentielle pour éviter les carences."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'exposition aux métaux lourds ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition."
}
},
{
"@type": "Question",
"name": "Comment réduire le cholestérol par l'alimentation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol."
}
},
{
"@type": "Question",
"name": "Quels aliments riches en calcium pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets secondaires des séquestrants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour le cholestérol ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les agents séquestrants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des agents séquestrants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment administrer un agent séquestrant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement pris par voie orale, souvent mélangés à des liquides."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour les métaux lourds ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une surconsommation d'agents séquestrants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels risques d'une utilisation prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences."
}
},
{
"@type": "Question",
"name": "Comment les agents séquestrants affectent-ils l'absorption des médicaments ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'intoxication au plomb ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, rénales et cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des agents séquestrants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carences ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication au mercure ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes consommant régulièrement des poissons contaminés sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels groupes sont vulnérables aux carences en calcium ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'intoxication aux métaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent l'absorption des nutriments ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; Innovative Genomics Institute, Berkeley, CA 94720, USA. Electronic address: joseph.bondy-denomy@ucsf.edu.
Publications dans "Agents séquestrants" :
3 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: fengyue@mail.buct.edu.cn.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Science and Technology, Konkuk University, Seoul 05029, Korea.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), 10117, Berlin, Germany. dragomir.milovanovic@dzne.de.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, School of Science, The University of Tokyo, Tokyo, Japan. ozawa@chem.s.u-tokyo.ac.jp.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
ABLife BioBigData Institute, Wuhan, Hubei, China. yizhang@ablife.cc.
Center for Genome Analysis, ABLife Inc., Wuhan, Hubei, China. yizhang@ablife.cc.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Stanford University, Stanford, CA 94305, USA; Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Publications dans "Agents séquestrants" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Stanford University, Stanford, CA 94305, USA; Sarafan ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Arc Institute, Palo Alto, CA 94304, USA.
Publications dans "Agents séquestrants" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University Shanghai 200438 China zhouw@fudan.edu.cn zhangdw@fudan.edu.cn ztli@fudan.edu.cn.
Publications dans "Agents séquestrants" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University Shanghai 200438 China zhouw@fudan.edu.cn zhangdw@fudan.edu.cn ztli@fudan.edu.cn.
Publications dans "Agents séquestrants" :
The production of reactor-based medical isotopes is fragile, which has meant supply shortages from time to time. This paper reviews alternative production methods in the form of cyclotrons, linear acc...
T...
The purpose of this work is to demonstrate the feasibility of the accelerated T...
The proposed method was validated in a numerical phantom, where two T...
Numerical simulations demonstrated that, for all noise levels, T...
Using the proposed approach, a retrospective data-driven gradient delay correction can be performed, which is particularly relevant for hybrid devices, where full information on the machine configurat...
Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the ad...
Up to 30 patients will be recruited over a 12-month period for participation in this Human Research Ethics Committee approved exploratory cohort study. Patients will be scanned on the magnetic resonan...
The results of this study will be used to assess the feasibility of treating patients with APBI in the prone position on a custom designed board on the MRL. It may also be used to assist with identifi...
Stereotactic radiotherapy gains more and more importance in the management of malignant melanoma, owing to technical developments of recent years. This approach might be applied with success in solita...
This study aimed to explore the effect of carbon fiber couch on radiotherapy dose attenuation and gamma pass rate in intensity-modulated radiotherapy (IMRT) plans. A phantom inserted with an ionizatio...
The use of relatively narrow fields has become necessary with the advent of intricate and accurate radiation therapy delivery dose to patients; therefore, small-field dosimetry faces several difficult...
In this study, we investigated the effect of detectors size on the dosimetry of small fields [starting with radiation fields from (1cm x 1cm), (2cm x 1cm), and (3cm x 1cm)...etc., up to (4cm x 5cm) an...
While measuring the absolute dose under reference conditions, all detectors had a non-significant difference of less than ±2%, except for the Razor diode, which showed a significant difference of ± 5%...
The Razor diode is more stable in small-field dosimetry than other detectors. Also, the Razor Diode is intended for relative dosimetry but, it shall not be used for absolute dose measurements....
Consistency and clear guidelines on dosimetry are essential for accurate and precise dosimetry, to ensure the best patient outcomes and to allow direct dose comparison across different centres. Magnet...
Breakthrough multi-response miniature dosimetry/spectrometry of electroneutrons (EN) was made on surface and in-depths of whole-body polyethylene phantom under 10 cm × 10 cm electron beam of 20 MV Var...
Magnetic Resonance Imaging linear-accelerator (MRI-linac) equipment has recently been introduced to multiple centres in Australia and New Zealand. MRI equipment creates hazards for staff, patients and...
The recent trend toward 10 MV for volumetric radiotherapy treatment such as volumetric modulated arc therapy (VMAT), stereotactic radiosurgery (SRS), and stereotactic ablative body radiotherapy (SABR)...
To measure photoneutron yields in a medical linac at 8 MV, which may strike a reasonable balance between usefully increased beam penetration and dose rate as compared to 6 MV while reducing photoneutr...
A Varian iX linear accelerator undergoing decommissioning at our clinic was made to operate over a range of photon energies between 6 and 15 MV by calibrating the bending magnet and adjusting other be...
The photoneutron production for energies below 10 MV was measured, adding to data that is otherwise scarce in the literature. Our results are consistent with previously published results for neutron y...
Photoneutron production drops off below 10 MV, but is still present at 8 MV. An 8 MV beam is more penetrating than a 6 MV beam, and may offer a suitable tradeoff for modern radiotherapy techniques suc...